BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6134311)

  • 1. [A biochemical study on the mechanism of action of beta-adrenergic blockers].
    Kawata S; Nishio M; Furuse T; Mashiba H
    Kokyu To Junkan; 1983 Jan; 31(1):29-31. PubMed ID: 6134311
    [No Abstract]   [Full Text] [Related]  

  • 2. [The beta 2-pseudoselectivity of ISA (intrinsic sympathomimetic action)--consequences for differential therapy with beta-blockers with and without ISA?].
    Werdan K; Reithmann C
    Dtsch Med Wochenschr; 1988 Feb; 113(7):272-4. PubMed ID: 2893724
    [No Abstract]   [Full Text] [Related]  

  • 3. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.
    Waelbroeck M; Taton G; Delhaye M; Chatelain P; Camus JC; Pochet R; Leclerc JL; De Smet JM; Robberecht P; Christophe J
    Mol Pharmacol; 1983 Sep; 24(2):174-82. PubMed ID: 6136901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of temperature and ionic environment on antagonists binding to cardiac beta-adrenoceptors [proceedings].
    Millson DS; Smith BR; Rawlins MD
    Br J Pharmacol; 1979 Nov; 67(3):416P-417P. PubMed ID: 40655
    [No Abstract]   [Full Text] [Related]  

  • 5. [Interaction between receptors and biologically active substances in tumor cells].
    Solntseva TI; Khabarov SV; Mikhaevich IS
    Vestn Akad Med Nauk SSSR; 1986; (8):23-31. PubMed ID: 2876559
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology of beta-blockers: classical aspects and recent developments.
    Haeusler G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S1-9. PubMed ID: 11527109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
    Chen J; Zhang LF; Han C; Yu GS; Ma J
    J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the activity and distribution of beta-adrenoceptor antagonists in the rat using an ex vivo receptor binding assay [proceedings].
    Nahorski SR; Sriwatanakul K
    Br J Pharmacol; 1979 Nov; 67(3):415P. PubMed ID: 40654
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-adrenergic receptor signalling in stunned myocardium of conscious pigs.
    Sato S; Sato N; Kudej RK; Uechi M; Asai K; Shen YT; Ishikawa Y; Vatner SF; Vatner DE
    J Mol Cell Cardiol; 1997 May; 29(5):1387-400. PubMed ID: 9201624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Catecholamine content in the myocardium of growing rats with alpha- and beta-adrenergic blockades].
    Viktorov AP
    Farmakol Toksikol; 1983; 46(3):44-7. PubMed ID: 6134637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous urea as an autacoid: extrarenal and renal focuses.
    Temnyalov ND
    Auton Neurosci; 2008 Feb; 138(1-2):1-8. PubMed ID: 18037357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia.
    Morioka N; Tanabe H; Inoue A; Dohi T; Nakata Y
    Neurochem Int; 2009 Sep; 55(4):226-34. PubMed ID: 19524113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and ontogenesis of beta-adrenergic receptors in fetal and neonatal rabbit myocardium.
    Hatjis CG; McLaughlin MK
    J Dev Physiol; 1982 Dec; 4(6):327-38. PubMed ID: 6306091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the binding of beta-adrenoceptor blockers to microsomal Na+/K+-ATPase in guinea pig heart preparations.
    Almotrefi AA; Basco C; Moorji A; Dzimiri N
    Can J Physiol Pharmacol; 2001 Jan; 79(1):8-12. PubMed ID: 11201505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells.
    Pittman RN; Molinoff PB
    Mol Pharmacol; 1983 Nov; 24(3):398-408. PubMed ID: 6138704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacology of beta-receptor blockers].
    Schmitz W
    Z Kardiol; 1996; 85 Suppl 7():5-9. PubMed ID: 9082683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
    Zhu SJ; Toews ML
    Mol Pharmacol; 1994 Feb; 45(2):255-61. PubMed ID: 7906855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative regulation of beta-adrenergic function by hydrogen sulphide in the rat hearts.
    Yong QC; Pan TT; Hu LF; Bian JS
    J Mol Cell Cardiol; 2008 Apr; 44(4):701-10. PubMed ID: 18329040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntheses and beta-adrenergic binding affinities of (R)- and (S)-fluoronaphthyloxypropanolamines.
    Adejare A; Deal SA; Day MS
    Chirality; 1999; 11(2):144-8. PubMed ID: 9951404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: a functional role for receptor-receptor interaction in vivo.
    Barki-Harrington L; Luttrell LM; Rockman HA
    Circulation; 2003 Sep; 108(13):1611-8. PubMed ID: 12963634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.